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Introduction
Platelet α -granules contain over 250 proteins which participate in a diverse range of vital processes including hemostasis, tissue repair, angiogenesis, inflammation and host defense. [1] [2] [3] α -granules form in the megakaryocyte (MK) and their maturation continues in the circulating platelet by constitutive endocytosis. [4] [5] [6] During MK development, α -granule cargo synthesized in the trans-Golgi network or derived from endocytosis of plasma membranes is trafficked to multivesicular bodies (MVBs). 3, 7 Kinetic studies in MKs have demonstrated that MVBs are a subset of late endosomes that have undergone internal vesicle budding (MVB I) and further maturation (MVB II), with delivery of newly synthesized proteins leading to α -granule formation. 8 Although little is known about the intracellular trafficking of proteins in MKs, experiments using ultrathin cryosectioning and immunoelectron microscopy suggest that
MVBs are an intermediate stage in the formation of α -granules. 8 Several insights into platelet α -granule biogenesis have come from studying patients with Gray Platelet Syndrome (GPS, MIM 139090). GPS is characterized by variable thrombocytopenia and absence of platelet α -granules. Mutations in NBEAL2 [9] [10] [11] or GFI1B 12, 13 have been identified in some of the patients, however, the exact roles of those proteins in α -granules production are not clear. Studies using established mouse models that mimic the GPS phenotype (Nbeal2 -/-mice) have revealed that MKs underwent abnormal maturation and platelets lacked α -granules. These mice have defective hemostasis and thrombosis, as well as altered thrombo-inflammatory disease states and tissue repair after injury. [14] [15] [16] [17] Interestingly the most recent study 17 showed that MKs from NBEAL2 deficient mice contained α -granule numbers comparable to controls, which were lost after proplatelet formation.
Another inherited disorder where absence of α -granules is observed is Arthrogryposis, Renal dysfunction and Cholestasis syndrome (ARC, MIM 208085). ARC is a rare autosomal recessive multisystem disorder characterized by developmental and functional defects in several organs. The majority of reported patients with ARC died in infancy due to metabolic decompensation or bleeding related to intercurrent illness. 18 ARC is caused by mutations in VPS33B or VIPAS39 that encode the trafficking proteins VPS33B and VIPAR respectively, which together form a functional complex. [19] [20] [21] Agranular platelets in patients with ARC phenotype were first described in 1990. 22 Subsequent studies in patients with mutations in VPS33B confirmed the absence of platelet α -granules including deficiencies in endogenously synthesized and endocytosed α -granule proteins in this disorder. 18, [23] [24] [25] A previous study showed that half of the patients with ARC developed life-threatening hemorrage after 18 The involvement of VPS33B and its interacting partner, VIPAR, in α -granule formation is still poorly understood.
In the present study we have generated a tamoxifen-inducible mouse model of VPS33B deficiency in order to investigate the molecular basis of the defect in α -granule biogenesis.
Here for the first time we demonstrate abnormal protein content in MVBs as well as deficiency in α -granule production in VPS33B deficient mice, which suggests that VPS33B
regulates protein sorting into α -granule destined organelles. Our results lead us to conclude that VPS33B is a key regulator of MVB maturation during megakaryopoiesis. 
Methods

Vps33b
Statistical analysis
Results are shown as mean ± SEM unless otherwise stated. Statistical analysis was performed with GraphPad Prism 5 (San Diego, CA) using the Student's t-test or Mann-Whitney test. P < .05 was considered as statistically significant. Figure S3A) . The presence of the latter population may be due to the existence of megakaryocyte precursors that have escaped CreER T2 -recombinase Vps33b excision.
Results
Characterization of
Whole mount EM showed that the number of δ-granules was not altered in -ER T2 mice that lack α -granules ( Figure 2C ).
These structures were also observed in two ARC patients with mutations in VPS33B and one patient with a mutation in VIPAS39, but were absent in controls ( Figure 2D ). Over 70% of patients' platelets were devoid of α -granules in agreement with previous reports (Supplemental Figure S4 ). 23 Immunogold labeling on cryosections for VWF, a protein stored in α -granules, showed the presence of this secreted protein in the small α -granule-like structures ( Figure 2E) that were observed by TEM suggesting that these granules could be a consequence of defective α -granule formation. Moreover, platelet VWF content determined by immunoblotting and densitometry ( Figure 3A ) was reduced by approximately 65% in
Vps33b
fl/fl -ER T2 platelets compared to controls (n = 3-5; P < .05). Similarly, a significant reduction around 75% was observed in P-selectin content ( Figure 3A ). Flow cytometric analysis measuring P-selectin surface expression in washed platelets was used as a marker for platelets with normal α -granules and the localization of cargo proteins to alternative compartments such as the small granules may explain why the difference in VWF and Pselectin levels is not more pronounced. (Table 3) .
A bleeding diathesis
We also investigated if the lack of VPS33B would affect endocytosis. Cultured MKs were incubated with fluorescently-labeled fibrinogen for 2 hours and the level of uptake was assessed by flow cytometry. There was no difference in fibrinogen uptake between control and Vps33b fl/fl -ER T2 -derived MKs ( Figure 6C ). This suggested that sorting of newly synthesized (and not endocytosed) proteins into α -granule progenitor MVBs was the most likely reason for the α -granule biogenesis defects.
We then asked the question whether VWF can be trafficked to proplatelet extensions during proplatelet formation despite the absence of normal-sized α -granules. Figures S6A-B 
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The observation that VPS33B deficient platelets lack α -granules but contain δ -granules, whereas Vps33a mutant platelets are devoid of δ -granules but contain α -granules suggests that VPS33A and VPS33B are involved in two distinct mechanisms by which these granules develop from MKs. It has been shown that in maturing bone marrow MKs δ -granule cargo originates from small vesicles budding from early endosome-associated tubules. 41, 42 In contrast platelet α -granules receive their cargo from the endocytic pathway as well as from the trans-Golgi network. Thus, it could be proposed that VPS33A as part of HOPS or CORVET is important for sorting of proteins from endosomes into maturing MVBs leading to the formation of δ -granules ( Figure 7C ). On the other hand, VPS33B in complex with VIPAR is likely to be responsible for sorting of some cargoes from the trans-Golgi network to α -granule-destined MVBs and subsequently promoting their maturation ( Figure 7C ). Tables   Table 1. Basic blood parameters All values are Mean ± SEM. ns = not significant; * P < .05; ** P < .01; *** P < .001. VPS33A and its interacting partner VPS16A are required for sorting of proteins from endosomes into maturing MVB II leading to the formation of δ -granules. On the other hand, VPS33B in complex with VIPAR is likely to be responsible for sorting of cargo from trans-
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